A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors - Regional Cancer Care Associates LLC

Clinical Trials

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Loxo Oncology
Protocol Number
Loxo Oncology LOXO-TRK-15002
Cancer Diagnosis
To Learn More Call
201-510-0910